1952

Everest Medicines Limited

HK Healthcare Biotechnology

Latest week
10 Jul 2026
Close
27.500000
Fair value
35.466795
Next-week expectancy
Negative 42.20%
Sharemaestro

1952 Chart Pack

Everest Medicines Limited

Exchange
HKG
Latest week
10 Jul 2026
Close
27.500000
Fair value
35.466795
Next-week expectancy
Negative 42.20%
Generated
17 Jul 2026 13:55
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, 1952 fell 25.68%, moving from 37.00 to 27.50. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -34.40 and has softened across the 12-week window. Market Dynamics is -0.88 on the latest week. Next-week expectancy is negative at 42.20% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
27.50
12-Week Change
-25.68%
Trend Signal
Inactive
Next-Week Expectancy
Negative 42.20%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-34.40
Market Dynamics
-0.88

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
27.50
12-Week Change
-25.68%
Trend Signal
Inactive
Next-Week Expectancy
Negative 42.20%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-34.40
Market Dynamics
-0.88

Over the latest 12 completed weeks ending 2026-07-10, 1952 fell 25.68%, moving from 37.00 to 27.50. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -34.40 and has softened across the 12-week window. Market Dynamics is -0.88 on the latest week. Next-week expectancy is negative at 42.20% based on similar historical setup states.

Industry Peers

Hong Kong equities in Biotechnology

Stock Exchange Week Open High Low Close Change
2565 PegBio Co., Ltd. HKG 10 Jul 2026 5.70 8.28 5.30 7.13 25.09%
2595 GenFleet Therapeutics (Shanghai) Inc. HKG 10 Jul 2026 32.00 40.98 30.54 38.36 19.88%
2315 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. HKG 10 Jul 2026 44.80 53.70 44.80 52.20 16.52%
2563 Beijing Biostar Pharmaceuticals Co., Ltd. HKG 10 Jul 2026 3.21 3.91 3.10 3.67 14.33%
3759 Pharmaron Beijing Co., Ltd. HKG 10 Jul 2026 19.78 23.16 19.00 22.60 14.28%
2410 TYK Medicines, Inc HKG 10 Jul 2026 6.59 7.75 6.32 7.26 10.17%
1521 Frontage Holdings Corporation HKG 10 Jul 2026 1.01 1.13 1.01 1.11 9.90%
1177 Sino Biopharmaceutical Limited HKG 10 Jul 2026 4.80 5.35 4.70 5.19 8.13%
2181 Mabpharm Limited HKG 10 Jul 2026 0.40 0.45 0.40 0.43 7.50%
2592 Cloudbreak Pharma Inc. HKG 10 Jul 2026 1.25 1.38 1.19 1.34 7.20%
3880 Medtide Inc. HKG 10 Jul 2026 22.22 24.20 22.00 23.80 7.11%
9969 InnoCare Pharma Limited HKG 10 Jul 2026 13.10 14.55 13.04 13.98 6.72%
2659 Shanghai Bao Pharmaceuticals Co., Ltd. HKG 10 Jul 2026 18.69 22.12 18.02 19.84 6.15%
9688 Zai Lab Limited HKG 10 Jul 2026 14.96 16.20 14.72 15.80 5.61%
1228 CANbridge Pharmaceuticals Inc. HKG 10 Jul 2026 1.96 2.16 1.86 2.03 3.57%
6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. HKG 10 Jul 2026 500.00 539.00 462.60 516.50 3.30%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.